Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Capital Expenditures: 2013-2025

Historic Capital Expenditures for Phibro Animal Health (PAHC) over the last 13 years, with Sep 2025 value amounting to $13.8 million.

  • Phibro Animal Health's Capital Expenditures rose 44.07% to $13.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $42.5 million, marking a year-over-year decrease of 1.91%. This contributed to the annual value of $38.3 million for FY2025, which is 7.14% down from last year.
  • As of Q3 2025, Phibro Animal Health's Capital Expenditures stood at $13.8 million, which was up 5.05% from $13.1 million recorded in Q2 2025.
  • Over the past 5 years, Phibro Animal Health's Capital Expenditures peaked at $23.2 million during Q3 2022, and registered a low of $7.1 million during Q2 2021.
  • In the last 3 years, Phibro Animal Health's Capital Expenditures had a median value of $9.7 million in 2024 and averaged $10.2 million.
  • As far as peak fluctuations go, Phibro Animal Health's Capital Expenditures spiked by 211.13% in 2022, and later crashed by 67.74% in 2023.
  • Over the past 5 years, Phibro Animal Health's Capital Expenditures (Quarterly) stood at $7.7 million in 2021, then grew by 27.69% to $9.8 million in 2022, then rose by 11.61% to $11.0 million in 2023, then fell by 28.62% to $7.8 million in 2024, then spiked by 44.07% to $13.8 million in 2025.
  • Its Capital Expenditures was $13.8 million in Q3 2025, compared to $13.1 million in Q2 2025 and $7.7 million in Q1 2025.